INFLAMMATION of the underlying layer of ADIPOSE TISSUE (panniculus) of the PERITONEUM, usually of the MESENTERY or the OMENTUM. There are several forms with various names and are usually characterized by infiltration of LYMPHOCYTES and NEUTROPHILS, fat NECROSIS, and FIBROSIS.
General term for the abnormal appearance of histiocytes in the blood. Based on the pathological features of the cells involved rather than on clinical findings, the histiocytic diseases are subdivided into three groups: HISTIOCYTOSIS, LANGERHANS CELL; HISTIOCYTOSIS, NON-LANGERHANS-CELL; and HISTIOCYTIC DISORDERS, MALIGNANT.
An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.
A type of panniculitis characterized histologically by the presence of granulomas, vasculitis, and necrosis. It is traditionally considered to be the tuberculous counterpart of nodular vasculitis, but is now known to occur without tuberculous precedent. It is seen most commonly in adolescent and menopausal women, is initiated or exacerbated by cold weather, and typically presents as one or more recurrent erythrocyanotic nodules or plaques on the calves. The nodules may progress to form indurations, ulcerations, and scars.
Acute or chronic INFLAMMATION of the PANCREAS due to excessive ALCOHOL DRINKING. Alcoholic pancreatitis usually presents as an acute episode but it is a chronic progressive disease in alcoholics.
Macrophages found in the TISSUES, as opposed to those found in the blood (MONOCYTES) or serous cavities (SEROUS MEMBRANE).
A type of lupus erythematosus characterized by deep dermal or subcutaneous nodules, most often on the head, face, or upper arms. It is generally chronic and occurs most often in women between the ages of 20 and 45.
The engulfment and degradation of cells by other cells.
Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of causes.
Infections with nematodes of the genus GNATHOSTOMA, superfamily THELAZIOIDEA. Gnathostomiasis is a food-borne zoonosis caused by eating undercooked or raw fish or meat.
A form of panniculitis characterized by recurrent episodes of fever accompanied by the eruption of single or multiple erythematous subcutaneous nodules on the lower extremities. They normally resolve, but tend to leave depressions in the skin. The condition is most often seen in women, alone or in association with other disorders.
General term for inflammation of adipose tissue, usually of the skin, characterized by reddened subcutaneous nodules.
'Skin diseases' is a broad term for various conditions affecting the skin, including inflammatory disorders, infections, benign and malignant tumors, congenital abnormalities, and degenerative diseases, which can cause symptoms such as rashes, discoloration, eruptions, lesions, itching, or pain.
A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES; SEZARY SYNDROME; LYMPHOMATOID PAPULOSIS; and PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA are the best characterized of these disorders.
A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)
A severe form of acute INFLAMMATION of the PANCREAS characterized by one or more areas of NECROSIS in the pancreas with varying degree of involvement of the surrounding tissues or organ systems. Massive pancreatic necrosis may lead to DIABETES MELLITUS, and malabsorption.
A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
A spontaneous diminution or abatement of a disease over time, without formal treatment.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES.
A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
A characteristic symptom complex.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
A broad-spectrum antimicrobial carboxyfluoroquinoline.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
Substances that reduce the growth or reproduction of BACTERIA.
A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.

Mesenteric panniculitis presenting as a huge retroperitoneal mass--a case report. (1/18)

A rare case of mesenteric panniculitis occurring in a young patient and presenting as a huge retroperitoneal mass which was mistaken for malignancy, has been described.  (+info)

A pilot study of thalidomide for patients with symptomatic mesenteric panniculitis. (2/18)

BACKGROUND: Mesenteric panniculitis is a rare condition with no standard therapy. AIM: To assess the safety and efficacy of thalidomide for the treatment of patients with symptomatic mesenteric panniculitis using a newly established clinical disease activity index (Mesenteric Panniculitis Subjective Assessment Score). METHODS: In an open-label pilot study, five patients with symptomatic mesenteric panniculitis received oral thalidomide, 200 mg nightly, for 12 weeks. The primary end-point was a reduction in the Mesenteric Panniculitis Subjective Assessment Score by > or = 20% at 12 weeks or complete remission (absence of symptoms). RESULTS: Four (80%) of the five patients responded. The median Mesenteric Panniculitis Subjective Assessment Score at baseline was 39 and at week 12 was 25 (average decrease of 44%). One patient achieved complete remission by week 4, which was sustained. At 12 weeks, three (75%) patients experienced a global response, five (100%) patients had a > or = 20% (range, 29-98%) decrease in erythrocyte sedimentation rate and three (75%) patients had a > or = 20% (range, 61-93%) decrease in C-reactive protein. Abdomino-pelvic computed tomography scans were unchanged in all five patients. There were no serious adverse events. CONCLUSIONS: Thalidomide is safe, well tolerated and efficacious in the treatment of some patients with symptomatic mesenteric panniculitis. Further study is indicated.  (+info)

Retractile mesenteritis presenting as protein-losing gastroenteropathy. (3/18)

Retractile mesenteritis is a rare, idiopathic condition characterized by nonspecific inflammation of the mesenteric adipose tissue. The majority of patients present with abdominal pain and/or a palpable mass. In the present report, a 68-year-old man with peripheral edema and mild hypoalbuminemia is presented. Protein-losing gastro-enteropathy was confirmed with an abnormal stool alpha1-antitrypsin clearance test and retractile mesenteritis was diagnosed at laparoscopy. This rare condition may respond to therapy with corticosteroids, azathioprine, cyclophosphamide, colchicine, progesterone, tamoxifen or thalidomide. Gastroenterologists should consider the diagnosis of protein-losing enteropathy in patients who present with unexplained peripheral edema or hypoalbuminemia. The test of choice to confirm this diagnosis is the stool alpha1-antitrypsin clearance test.  (+info)

Occasional finding of mesenteric lipodystrophy during laparoscopy: a difficult diagnosis. (4/18)

Mesenteric lipodystrophy is a rare pathological condition affecting the mesentery. Its initial presentation is typically asymptomatic. Pathological characteristics are unspecific, and generally attributed to inflammation, unless the diagnosis is suspected. Laparoscopy done for other reasons has been, as in this case, unsuccessful in providing evidence for the correct diagnosis, thus requiring laparotomy due to lack of diagnostic tissue. After 6 mo no further medical therapy is required, as the patient remains asymptomatic. Discussion of this case and a brief review of the literature are presented in the following paragraphs.  (+info)

Retractile mesenteritis presenting with malabsorption syndrome. Successful treatment with oral pentoxifylline. (5/18)

Retractile mesenteritis is a rare benign inflammatory disease of the mesentery. Computed tomographic findings usually suggest the diagnosis, which is confirmed by surgical biopsies. Conservative treatment is empirical, based on corticosteroids, colchicine, immunosuppressive agents and progesterone. Surgical resection is sometimes attempted for definitive therapy, although the surgical approach is often limited. This report describes a 62-year old man with histologically proven retractile mesenteritis presenting with malabsorbtion syndrome, who presented pulmonary tuberculosis after initial therapy with corticosteroids. He was subsequently treated with oral pentoxifylline (800 mg/day), with substantial clinical and radiological improvement.  (+info)

Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma. (6/18)

 (+info)

An unusual presentation of sclerosing mesenteritis as pneumoperitoneum: case report with a review of the literature. (7/18)

Sclerosing mesenteritis is a rare condition that involves the small or large bowel mesentery. An unusual presentation of this condition, which led to difficult preoperative assessment and diagnosis, is described. This report is followed by a comprehensive review of the literature.  (+info)

Mesenteric panniculitis: various presentations and treatment regimens. (8/18)

Mesenteric panniculitis is a rare, benign and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery of the small intestine and colon. The specific etiology of the disease is unknown. The diagnosis is suggested by computed tomography and is usually confirmed by surgical biopsies. Treatment is empirical and based on a few selected drugs. Surgical resection is sometimes attempted for definitive therapy, although the surgical approach is often limited. We report two cases of mesenteric panniculitis with two different presentations and subsequently varying treatment regimens. Adequate response was obtained in both patients. We present details of these cases as well as a literature review to compare various presentations, etiologies and potential treatment modalities.  (+info)

Peritoneal panniculitis is a rare inflammatory condition that affects the fatty tissue (panniculus) in the peritoneum, which is the thin membrane that lines the inside of the abdominal cavity and covers the organs within it. The condition is characterized by the accumulation of inflammatory cells in the fatty tissue, leading to nodular or diffuse enlargement and subsequent necrosis (death) of the adipose tissue.

Peritoneal panniculitis can occur as a primary disorder or secondary to other medical conditions such as malignancies, infections, autoimmune diseases, or reactions to medications. The exact cause of primary peritoneal panniculitis remains unclear. Symptoms may include abdominal pain, bloating, fever, weight loss, and elevated white blood cell count. Diagnosis typically involves imaging studies (such as CT or MRI scans) and confirmation through biopsy of the affected tissue. Treatment depends on the underlying cause but often includes corticosteroids and other immunosuppressive medications to manage the inflammation.

Histiocytosis is a term used to describe a group of rare disorders characterized by an abnormal increase in the number of histiocytes, which are a type of white blood cell that helps fight infection and helps in healing processes. These disorders can affect various organs and tissues in the body, leading to different symptoms and severity.

There are several types of histiocytosis, including Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD), and hemophagocytic lymphohistiocytosis (HLH). Each type has its own specific features and diagnostic criteria.

For example, LCH is characterized by the abnormal accumulation of Langerhans cells, a type of histiocyte found in the skin and mucous membranes. These cells can form tumors or lesions in various organs, such as the bones, lungs, liver, and skin.

HLH, on the other hand, is a life-threatening condition that occurs when there is an overactive immune response leading to excessive activation of histiocytes and other immune cells. This can result in fever, enlargement of the liver and spleen, and decreased blood cell counts.

The exact cause of histiocytosis is not fully understood, but it is believed to involve genetic mutations that lead to uncontrolled proliferation and accumulation of histiocytes. Treatment for histiocytosis depends on the type and severity of the disorder and may include chemotherapy, radiation therapy, immunosuppressive drugs, or stem cell transplantation.

Erythema nodosum is a type of inflammation that occurs in the fatty layer of the skin, causing painful, red or purple bumps (nodules) to form. It is a type of panniculitis, which refers to any condition that causes inflammation of the fatty layer of tissue beneath the skin.

Erythema nodosum is often associated with a variety of underlying conditions, such as infections (e.g., streptococcus, tuberculosis), medications (e.g., sulfa drugs, oral contraceptives), inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis), and pregnancy.

The bumps associated with erythema nodosum typically appear on the shins, ankles, knees, or other areas of the legs, although they can also occur on the arms, hands, or face. The bumps may be tender to the touch, warm, and swollen, and they may cause pain or discomfort when walking or standing for prolonged periods.

In most cases, erythema nodosum resolves on its own within a few weeks to several months, although symptoms can be managed with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Treating the underlying condition is also important for resolving erythema nodosum and preventing recurrences.

Erythema induratum is a skin condition that is characterized by inflammation and hardening of the skin, usually occurring on the calves of the legs. It is also known as Bazin's disease. The condition typically affects young women and is thought to be related to tuberculosis infection.

The symptoms of erythema induratum include red, painful, and hard nodules or plaques on the skin that may ulcerate and form crusts. These lesions can be tender to the touch and may cause scarring. The condition often affects both legs and can be accompanied by fever, fatigue, and other systemic symptoms of tuberculosis.

The diagnosis of erythema induratum is typically made based on the clinical presentation of the skin lesions and confirmed with laboratory tests such as a biopsy or culture to detect tuberculosis infection. Treatment usually involves antibiotics to treat the underlying tuberculosis infection, as well as anti-inflammatory medications to manage the skin symptoms. In some cases, surgical removal of the lesions may be necessary.

Alcoholic pancreatitis is a specific type of pancreatitis, which is inflammation of the pancreas. This condition is caused by excessive and prolonged consumption of alcohol. The exact mechanism by which alcohol induces pancreatitis is not fully understood, but it is believed that alcohol causes damage to the cells of the pancreas, leading to inflammation. This can result in abdominal pain, nausea, vomiting, fever, and increased heart rate. Chronic alcoholic pancreatitis can also lead to serious complications such as diabetes, malnutrition, and pancreatic cancer. Treatment typically involves supportive care, such as hydration, pain management, and nutritional support, along with abstinence from alcohol. In severe cases, surgery may be necessary to remove damaged tissue or to relieve blockages in the pancreas.

Histiocytes are a type of immune cell that are part of the mononuclear phagocyte system. They originate from monocytes, which are derived from hematopoietic stem cells in the bone marrow. Histiocytes play an important role in the immune system by engulfing and destroying foreign substances, such as bacteria and viruses, as well as removing dead cells and other debris from the body. They can be found in various tissues throughout the body, including the skin, lymph nodes, spleen, and liver.

Histiocytes include several different types of cells, such as macrophages, dendritic cells, and Langerhans cells. These cells have different functions but all play a role in the immune response. For example, macrophages are involved in inflammation and tissue repair, while dendritic cells are important for presenting antigens to T cells and initiating an immune response.

Abnormal accumulations or dysfunction of histiocytes can lead to various diseases, such as histiocytosis, which is a group of disorders characterized by the abnormal proliferation and accumulation of histiocytes in various tissues.

Lupus erythematosus panniculitis (LEP), also known as lupus profundus, is a type of cutaneous lupus erythematosus (CLE) that affects the fatty layer under the skin (subcutaneous tissue). It is characterized by deep inflammation of the fatty tissue, leading to nodular or indurated (hardened) plaques and subcutaneous ulcerations. The lesions are typically tender and can be painful. LEP most commonly affects the face, trunk, and proximal extremities.

LEP is associated with systemic lupus erythematosus (SLE), but it can also occur in isolation without evidence of systemic involvement. It is estimated that approximately 1-10% of patients with SLE develop LEP. The exact pathogenesis of LEP remains unclear, but it is thought to involve an autoimmune response directed against the fatty tissue.

Histologically, LEP is characterized by lobular panniculitis with lymphocytic infiltration and fat necrosis. Direct immunofluorescence may show deposition of immune complexes along the blood vessels in the affected area.

Treatment of LEP can be challenging, and often requires a multidisciplinary approach involving dermatologists, rheumatologists, and other specialists. Systemic therapies such as corticosteroids, antimalarials, immunosuppressive agents, and biologics may be used to control the disease activity. In addition, local treatments such as intralesional steroid injections or surgical excision of lesions may be considered for refractory cases.

Cytophagocytosis is a medical term that refers to the process in which certain types of cells, particularly immune cells like macrophages, engulf and digest other smaller cells or particles. This process helps the body to eliminate foreign substances, cellular debris, and pathogens such as bacteria, viruses, and fungi.

During cytophagocytosis, the macrophage extends its pseudopodia (cytoplasmic extensions) to surround and engulf the target cell or particle, forming a vesicle called a phagosome. The phagosome then fuses with a lysosome, an organelle containing digestive enzymes, which breaks down the contents of the phagosome into smaller molecules that can be used by the macrophage for energy or eliminated as waste products.

Cytophagocytosis is an essential part of the immune system's defense mechanisms and plays a crucial role in maintaining tissue homeostasis and preventing infection and disease.

Erythema is a term used in medicine to describe redness of the skin, which occurs as a result of increased blood flow in the superficial capillaries. This redness can be caused by various factors such as inflammation, infection, trauma, or exposure to heat, cold, or ultraviolet radiation. In some cases, erythema may also be accompanied by other symptoms such as swelling, warmth, pain, or itching. It is a common finding in many medical conditions and can vary in severity from mild to severe.

Gnathostomiasis is a parasitic infection caused by the third-stage larvae of nematodes (roundworms) in the genus Gnathostoma. The infection typically occurs through the consumption of raw or undercooked freshwater fish, amphibians, or birds that contain the parasite's larvae.

The third-stage larvae penetrate the gastrointestinal tract and migrate to various tissues, including the skin, subcutaneous tissue, eyes, and central nervous system, causing cutaneous, ocular, or visceral lesions. The clinical manifestations of gnathostomiasis depend on the migration pathway and the organs involved.

Symptoms can range from mild dermatological reactions to severe neurological complications, such as eosinophilic meningitis or encephalitis. Diagnosis is often challenging due to its nonspecific clinical presentation and requires a high index of suspicion in travelers returning from endemic areas.

The disease is prevalent in Southeast Asia, East Asia, and Central and South America. Preventive measures include avoiding the consumption of raw or undercooked fish, amphibians, or birds in endemic regions and practicing good hygiene.

Nodular nonsuppurative panniculitis is a rare inflammatory condition that affects the subcutaneous fat tissue. The term "nonsuppurative" indicates that it does not involve pus formation or suppuration, unlike some other forms of panniculitis.

In nodular nonsuppurative panniculitis, multiple, firm, and occasionally tender nodules develop in the subcutaneous fat layer, usually on the lower extremities but can also occur on the abdomen, arms, and trunk. These nodules may vary in size from a few millimeters to several centimeters.

The etiology of nodular nonsuppurative panniculitis is not well understood, although it has been associated with various conditions such as autoimmune disorders (e.g., lupus erythematosus, rheumatoid arthritis), infections (e.g., hepatitis C, HIV), medications (e.g., bromocriptine, interferon), and malignancies (e.g., lymphoma).

Histologically, the condition is characterized by a lobular inflammatory infiltrate predominantly composed of lymphocytes, histiocytes, and occasionally plasma cells, with sparing of septa. The overlying skin may appear normal or show mild changes such as erythema or induration.

Treatment for nodular nonsuppurative panniculitis depends on the underlying cause. If an associated condition or medication is identified, addressing it may lead to resolution of the panniculitis. In cases where no specific cause is found, various treatments such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, immunosuppressive agents, and antimalarials have been used with varying success rates.

Panniculitis is a medical term that refers to inflammation of the subcutaneous fat, or the layer of fat located just beneath the skin. This condition can affect people of all ages and genders, although it is more commonly seen in middle-aged women. The inflammation can be caused by a variety of factors, including infections, autoimmune disorders, trauma, and medications.

The symptoms of panniculitis may include:

* Red, painful lumps or nodules under the skin
* Skin lesions that may be tender, warm, or bruised
* Swelling and redness in the affected area
* Fever, fatigue, and malaise (a general feeling of illness)

The diagnosis of panniculitis typically involves a physical examination, medical history, and sometimes a biopsy of the affected tissue. Treatment depends on the underlying cause of the inflammation and may include antibiotics, anti-inflammatory medications, or other therapies. In severe cases, hospitalization may be necessary to manage symptoms and prevent complications.

Skin diseases, also known as dermatological conditions, refer to any medical condition that affects the skin, which is the largest organ of the human body. These diseases can affect the skin's function, appearance, or overall health. They can be caused by various factors, including genetics, infections, allergies, environmental factors, and aging.

Skin diseases can present in many different forms, such as rashes, blisters, sores, discolorations, growths, or changes in texture. Some common examples of skin diseases include acne, eczema, psoriasis, dermatitis, fungal infections, viral infections, bacterial infections, and skin cancer.

The symptoms and severity of skin diseases can vary widely depending on the specific condition and individual factors. Some skin diseases are mild and can be treated with over-the-counter medications or topical creams, while others may require more intensive treatments such as prescription medications, light therapy, or even surgery.

It is important to seek medical attention if you experience any unusual or persistent changes in your skin, as some skin diseases can be serious or indicative of other underlying health conditions. A dermatologist is a medical doctor who specializes in the diagnosis and treatment of skin diseases.

Cutaneous T-cell lymphoma (CTCL) is a type of cancer that affects T-cells, a specific group of white blood cells called lymphocytes. These cells play a crucial role in the body's immune system and help protect against infection and disease. In CTCL, the T-cells become malignant and accumulate in the skin, leading to various skin symptoms and lesions.

CTCL is a subtype of non-Hodgkin lymphoma (NHL), which refers to a group of cancers that originate from lymphocytes. Within NHL, CTCL is categorized as a type of extranodal lymphoma since it primarily involves organs or tissues outside the lymphatic system, in this case, the skin.

The two most common subtypes of CTCL are mycosis fungoides and Sézary syndrome:

1. Mycosis fungoides (MF): This is the more prevalent form of CTCL, characterized by patches, plaques, or tumors on the skin. The lesions may be scaly, itchy, or change in size, shape, and color over time. MF usually progresses slowly, with early-stage disease often confined to the skin for several years before spreading to lymph nodes or other organs.
2. Sézary syndrome (SS): This is a more aggressive form of CTCL that involves not only the skin but also the blood and lymph nodes. SS is characterized by the presence of malignant T-cells, known as Sézary cells, in the peripheral blood. Patients with SS typically have generalized erythroderma (reddening and scaling of the entire body), pruritus (severe itching), lymphadenopathy (swollen lymph nodes), and alopecia (hair loss).

The diagnosis of CTCL usually involves a combination of clinical examination, skin biopsy, and immunophenotyping to identify the malignant T-cells. Treatment options depend on the stage and subtype of the disease and may include topical therapies, phototherapy, systemic medications, or targeted therapies.

Dermatomyositis is a medical condition characterized by inflammation and weakness in the muscles and skin. It is a type of inflammatory myopathy, which means that it causes muscle inflammation and damage. Dermatomyositis is often associated with a distinctive rash that affects the skin around the eyes, nose, mouth, fingers, and toes.

The symptoms of dermatomyositis can include:

* Progressive muscle weakness, particularly in the hips, thighs, shoulders, and neck
* Fatigue
* Difficulty swallowing or speaking
* Skin rash, which may be pink or purple and is often accompanied by itching
* Muscle pain and tenderness
* Joint pain and swelling
* Raynaud's phenomenon, a condition that affects blood flow to the fingers and toes

The exact cause of dermatomyositis is not known, but it is believed to be related to an autoimmune response in which the body's immune system mistakenly attacks healthy tissue. Treatment for dermatomyositis typically involves medications to reduce inflammation and suppress the immune system, as well as physical therapy to help maintain muscle strength and function.

Acute necrotizing pancreatitis is a severe and potentially life-threatening form of acute pancreatitis, which is an inflammatory condition of the pancreas. In acute necrotizing pancreatitis, there is widespread death (necrosis) of pancreatic tissue due to autodigestion caused by the activation and release of digestive enzymes within the pancreas. This condition can lead to systemic inflammation, organ failure, and infection of the necrotic areas in the pancreas. It typically has a more complicated clinical course and worse prognosis compared to acute interstitial pancreatitis, which is another form of acute pancreatitis without significant necrosis.

Prednisolone is a synthetic glucocorticoid drug, which is a class of steroid hormones. It is commonly used in the treatment of various inflammatory and autoimmune conditions due to its potent anti-inflammatory and immunosuppressive effects. Prednisolone works by binding to specific receptors in cells, leading to changes in gene expression that reduce the production of substances involved in inflammation, such as cytokines and prostaglandins.

Prednisolone is available in various forms, including tablets, syrups, and injectable solutions. It can be used to treat a wide range of medical conditions, including asthma, rheumatoid arthritis, inflammatory bowel disease, allergies, skin conditions, and certain types of cancer.

Like other steroid medications, prednisolone can have significant side effects if used in high doses or for long periods of time. These may include weight gain, mood changes, increased risk of infections, osteoporosis, diabetes, and adrenal suppression. As a result, the use of prednisolone should be closely monitored by a healthcare professional to ensure that its benefits outweigh its risks.

Spontaneous remission in a medical context refers to the disappearance or significant improvement of symptoms of a disease or condition without any specific treatment being administered. In other words, it's a situation where the disease resolves on its own, without any apparent cause. While spontaneous remission can occur in various conditions, it is relatively rare and not well understood. It's important to note that just because a remission occurs without treatment doesn't mean that medical care should be avoided, as many conditions can worsen or lead to complications if left untreated.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

A biopsy is a medical procedure in which a small sample of tissue is taken from the body to be examined under a microscope for the presence of disease. This can help doctors diagnose and monitor various medical conditions, such as cancer, infections, or autoimmune disorders. The type of biopsy performed will depend on the location and nature of the suspected condition. Some common types of biopsies include:

1. Incisional biopsy: In this procedure, a surgeon removes a piece of tissue from an abnormal area using a scalpel or other surgical instrument. This type of biopsy is often used when the lesion is too large to be removed entirely during the initial biopsy.

2. Excisional biopsy: An excisional biopsy involves removing the entire abnormal area, along with a margin of healthy tissue surrounding it. This technique is typically employed for smaller lesions or when cancer is suspected.

3. Needle biopsy: A needle biopsy uses a thin, hollow needle to extract cells or fluid from the body. There are two main types of needle biopsies: fine-needle aspiration (FNA) and core needle biopsy. FNA extracts loose cells, while a core needle biopsy removes a small piece of tissue.

4. Punch biopsy: In a punch biopsy, a round, sharp tool is used to remove a small cylindrical sample of skin tissue. This type of biopsy is often used for evaluating rashes or other skin abnormalities.

5. Shave biopsy: During a shave biopsy, a thin slice of tissue is removed from the surface of the skin using a sharp razor-like instrument. This technique is typically used for superficial lesions or growths on the skin.

After the biopsy sample has been collected, it is sent to a laboratory where a pathologist will examine the tissue under a microscope and provide a diagnosis based on their findings. The results of the biopsy can help guide further treatment decisions and determine the best course of action for managing the patient's condition.

In medical terms, the skin is the largest organ of the human body. It consists of two main layers: the epidermis (outer layer) and dermis (inner layer), as well as accessory structures like hair follicles, sweat glands, and oil glands. The skin plays a crucial role in protecting us from external factors such as bacteria, viruses, and environmental hazards, while also regulating body temperature and enabling the sense of touch.

Alpha 1-antitrypsin (AAT, or α1-antiproteinase, A1AP) is a protein that is primarily produced by the liver and released into the bloodstream. It belongs to a group of proteins called serine protease inhibitors, which help regulate inflammation and protect tissues from damage caused by enzymes involved in the immune response.

Alpha 1-antitrypsin is particularly important for protecting the lungs from damage caused by neutrophil elastase, an enzyme released by white blood cells called neutrophils during inflammation. In the lungs, AAT binds to and inhibits neutrophil elastase, preventing it from degrading the extracellular matrix and damaging lung tissue.

Deficiency in alpha 1-antitrypsin can lead to chronic obstructive pulmonary disease (COPD) and liver disease. The most common cause of AAT deficiency is a genetic mutation that results in abnormal folding and accumulation of the protein within liver cells, leading to reduced levels of functional AAT in the bloodstream. This condition is called alpha 1-antitrypsin deficiency (AATD) and can be inherited in an autosomal codominant manner. Individuals with severe AATD may require augmentation therapy with intravenous infusions of purified human AAT to help prevent lung damage.

Cyclosporine is a medication that belongs to a class of drugs called immunosuppressants. It is primarily used to prevent the rejection of transplanted organs, such as kidneys, livers, and hearts. Cyclosporine works by suppressing the activity of the immune system, which helps to reduce the risk of the body attacking the transplanted organ.

In addition to its use in organ transplantation, cyclosporine may also be used to treat certain autoimmune diseases, such as rheumatoid arthritis and psoriasis. It does this by suppressing the overactive immune response that contributes to these conditions.

Cyclosporine is available in capsule, oral solution, and injectable forms. Common side effects of the medication include kidney problems, high blood pressure, tremors, headache, and nausea. Long-term use of cyclosporine can also increase the risk of certain types of cancer and infections.

It is important to note that cyclosporine should only be used under the close supervision of a healthcare provider, as it requires regular monitoring of blood levels and kidney function.

Immunosuppressive agents are medications that decrease the activity of the immune system. They are often used to prevent the rejection of transplanted organs and to treat autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. These drugs work by interfering with the immune system's normal responses, which helps to reduce inflammation and damage to tissues. However, because they suppress the immune system, people who take immunosuppressive agents are at increased risk for infections and other complications. Examples of immunosuppressive agents include corticosteroids, azathioprine, cyclophosphamide, mycophenolate mofetil, tacrolimus, and sirolimus.

A syndrome, in medical terms, is a set of symptoms that collectively indicate or characterize a disease, disorder, or underlying pathological process. It's essentially a collection of signs and/or symptoms that frequently occur together and can suggest a particular cause or condition, even though the exact physiological mechanisms might not be fully understood.

For example, Down syndrome is characterized by specific physical features, cognitive delays, and other developmental issues resulting from an extra copy of chromosome 21. Similarly, metabolic syndromes like diabetes mellitus type 2 involve a group of risk factors such as obesity, high blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels that collectively increase the risk of heart disease, stroke, and diabetes.

It's important to note that a syndrome is not a specific diagnosis; rather, it's a pattern of symptoms that can help guide further diagnostic evaluation and management.

X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.

The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.

CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.

In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.

CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.

In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.

Ciprofloxacin is a fluoroquinolone antibiotic that is used to treat various types of bacterial infections, including respiratory, urinary, and skin infections. It works by inhibiting the bacterial DNA gyrase, which is an enzyme necessary for bacterial replication and transcription. This leads to bacterial cell death. Ciprofloxacin is available in oral and injectable forms and is usually prescribed to be taken twice a day. Common side effects include nausea, diarrhea, and headache. It may also cause serious adverse reactions such as tendinitis, tendon rupture, peripheral neuropathy, and central nervous system effects. It is important to note that ciprofloxacin should not be used in patients with a history of hypersensitivity to fluoroquinolones and should be used with caution in patients with a history of seizures, brain injury, or other neurological conditions.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Anti-infective agents are a class of medications that are used to treat infections caused by various microorganisms such as bacteria, viruses, fungi, and parasites. These agents work by either killing the microorganism or inhibiting its growth, thereby helping to control the infection and alleviate symptoms.

There are several types of anti-infective agents, including:

1. Antibiotics: These are medications that are used to treat bacterial infections. They work by either killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic).
2. Antivirals: These are medications that are used to treat viral infections. They work by interfering with the replication of the virus, preventing it from spreading and causing further damage.
3. Antifungals: These are medications that are used to treat fungal infections. They work by disrupting the cell membrane of the fungus, killing it or inhibiting its growth.
4. Antiparasitics: These are medications that are used to treat parasitic infections. They work by either killing the parasite or inhibiting its growth and reproduction.

It is important to note that anti-infective agents are not effective against all types of infections, and it is essential to use them appropriately to avoid the development of drug-resistant strains of microorganisms.

Fluoroquinolones are a class of antibiotics that are widely used to treat various types of bacterial infections. They work by interfering with the bacteria's ability to replicate its DNA, which ultimately leads to the death of the bacterial cells. Fluoroquinolones are known for their broad-spectrum activity against both gram-positive and gram-negative bacteria.

Some common fluoroquinolones include ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin. These antibiotics are often used to treat respiratory infections, urinary tract infections, skin infections, and gastrointestinal infections, among others.

While fluoroquinolones are generally well-tolerated, they can cause serious side effects in some people, including tendonitis, nerve damage, and changes in mood or behavior. As with all antibiotics, it's important to use fluoroquinolones only when necessary and under the guidance of a healthcare provider.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Quinolones are a class of antibacterial agents that are widely used in medicine to treat various types of infections caused by susceptible bacteria. These synthetic drugs contain a chemical structure related to quinoline and have broad-spectrum activity against both Gram-positive and Gram-negative bacteria. Quinolones work by inhibiting the bacterial DNA gyrase or topoisomerase IV enzymes, which are essential for bacterial DNA replication, transcription, and repair.

The first quinolone antibiotic was nalidixic acid, discovered in 1962. Since then, several generations of quinolones have been developed, with each generation having improved antibacterial activity and a broader spectrum of action compared to the previous one. The various generations of quinolones include:

1. First-generation quinolones (e.g., nalidixic acid): Primarily used for treating urinary tract infections caused by Gram-negative bacteria.
2. Second-generation quinolones (e.g., ciprofloxacin, ofloxacin, norfloxacin): These drugs have improved activity against both Gram-positive and Gram-negative bacteria and are used to treat a wider range of infections, including respiratory, gastrointestinal, and skin infections.
3. Third-generation quinolones (e.g., levofloxacin, sparfloxacin, grepafloxacin): These drugs have enhanced activity against Gram-positive bacteria, including some anaerobes and atypical organisms like Legionella and Mycoplasma species.
4. Fourth-generation quinolones (e.g., moxifloxacin, gatifloxacin): These drugs have the broadest spectrum of activity, including enhanced activity against Gram-positive bacteria, anaerobes, and some methicillin-resistant Staphylococcus aureus (MRSA) strains.

Quinolones are generally well-tolerated, but like all medications, they can have side effects. Common adverse reactions include gastrointestinal symptoms (nausea, vomiting, diarrhea), headache, and dizziness. Serious side effects, such as tendinitis, tendon rupture, peripheral neuropathy, and QT interval prolongation, are less common but can occur, particularly in older patients or those with underlying medical conditions. The use of quinolones should be avoided or used cautiously in these populations.

Quinolone resistance has become an increasing concern due to the widespread use of these antibiotics. Bacteria can develop resistance through various mechanisms, including chromosomal mutations and the acquisition of plasmid-mediated quinolone resistance genes. The overuse and misuse of quinolones contribute to the emergence and spread of resistant strains, which can limit treatment options for severe infections caused by these bacteria. Therefore, it is essential to use quinolones judiciously and only when clinically indicated, to help preserve their effectiveness and prevent further resistance development.

... panniculitis, nodular nonsuppurative MeSH C17.300.710.600 - panniculitis, peritoneal MeSH C17.300.775.099 - arthritis, ... panniculitis, lupus erythematosus MeSH C17.800.566.500 - panniculitis, nodular nonsuppurative MeSH C17.800.600.325 - dermatitis ... panniculitis, lupus erythematosus MeSH C17.300.480.680 - lupus nephritis MeSH C17.300.480.750 - lupus vasculitis, central ... panniculitis, lupus erythematosus MeSH C17.800.508.236 - mastocytoma MeSH C17.800.508.473 - mastocytosis, cutaneous MeSH ...
For example, Banerjee et al[1989] reported two patients with autoimmune hepatitis and febrile panniculitis. On each occasion ... "Small Bowel Obstruction Caused by Peritoneal Immunoglobulin G4-Related Disease Mimicking Carcinomatosis: Case Report". Korean ... Chronic active hepatitis and febrile panniculitis. Gut 1989;30:1018-19 "Clinical Commissioning Policy: Rituximab for ... the panniculitis responded to increasing the doses ofprednisolone. At the 2011 International Symposium on IgG4-Related Diseases ...
... panniculitis, nodular nonsuppurative MeSH C17.300.710.600 - panniculitis, peritoneal MeSH C17.300.775.099 - arthritis, ... panniculitis, lupus erythematosus MeSH C17.800.566.500 - panniculitis, nodular nonsuppurative MeSH C17.800.600.325 - dermatitis ... panniculitis, lupus erythematosus MeSH C17.300.480.680 - lupus nephritis MeSH C17.300.480.750 - lupus vasculitis, central ... panniculitis, lupus erythematosus MeSH C17.800.508.236 - mastocytoma MeSH C17.800.508.473 - mastocytosis, cutaneous MeSH ...
Peritoneal Panniculitis 30% * Gastrointestinal Stromal Tumors 21% * Wnt Signaling Pathway 10% * Differential Diagnosis 7% ...
Paniculitis Peritoneal/diagnóstico; Paniculitis Peritoneal/diagnóstico por imagen; Tomografía Computarizada por Rayos X; ... Mesenteric panniculitis as a possible cause of fever of unknown origin. Mesenteric panniculitis as a possible cause of fever of ... Mesenteric panniculitis is a non-neoplastic condition involving inflammation and fibrosis of the small bowel mesentery. We ... The diagnosis of mesenteric panniculitis had been established 2 weeks prior based on an abdominal computerized tomography scan ...
Peritoneal Panniculitis Medicine & Life Sciences 100% * Renal Colic Medicine & Life Sciences 85% ... title = "Mimicker of Renal Colic: Mesenteric Panniculitis",. abstract = "A Mesenteric panniculitis is an uncommon disorder with ... Mimicker of Renal Colic: Mesenteric Panniculitis. / Canan, A. In: Journal of Nepal Health Research Council, Vol. 14, No. 33, ... Canan, A. (2016). Mimicker of Renal Colic: Mesenteric Panniculitis. Journal of Nepal Health Research Council, 14(33), 132-134. ...
Clinically a urachal primary with peritoneal metastases was a more likely diagnosis than IAF. At laparotomy in the absence of a ... Differential diagnosis includes mesenteric panniculitis and sclerosis, retroperitoneal fibrosis and gastrointestinal stromal ... He underwent a diagnostic debulking procedure; a dominant omental mass was removed and 2-3 mm peritoneal nodules on the distal ... Given the rarity of omental disease associated with DF, concerns remained that this could represent peritoneal surface ...
62. PANNICULITIS, PERITONEAL [ՊԱՆԻԿՈՒԼԻՏ ՊԵՐԻՏՈՆԵԱԼ (ՈՐՈՎԱՅՆԱՄԶԱԲՈՐԲԱՅԻՆ)] 13. PAINT [ՆԵՐԿԵՐ] 63. PANOPHTHALMITIS [ՊԱՆՕՖԹԱԼՄԻԱ ... 60. PANNICULITIS, LUPUS ERYTHEMATOSUS [ՊԱՆԻԿՈՒԼԻՏ ԳԱՅԼԱԽՏԱՅԻՆ] 11. PAIN, INTRACTABLE [ՑԱՎԵՐ ԱՆՎԵՐԱՑՆԵԼԻ] 61. PANNICULITIS, ... 59. PANNICULITIS [ՊԱՆԻԿՈՒԼԻՏ (ԵՆԹԱՄԱՇԿԱՅԻՆ ՃԱՐՊԱՇԱՐԱԿՑԱԿԱՆ ՇԵՐՏԻ ԲՈՐԲՈՔՈՒՄ)] 10. PAIN MEASUREMENT [ՑԱՎԵՐԻ ՀԵՏԱԶՈՏՈՒԹՅՈՒՆՆԵՐ] ...
Panniculitis, Peritoneal. *Paracentesis. *Paraneoplastic Syndromes. *Parenteral Nutrition. *Patient Discharge. *Patient ...
Mycobacterium fortuitum panniculitis in a steroid-dependent asthmatic patient. J Am Acad Dermatol. 1998 Oct; 39(4 Pt 1):650-3. ... "Panniculitis" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ... Manosca F, Ariga R, Bengana C, Reddy VB, Loew J, Gattuso P. Fine-needle aspiration of subcutaneous panniculitis-like T-cell ... This graph shows the total number of publications written about "Panniculitis" by people in this website by year, and whether " ...
Peritoneal Panniculitis. *Persistent fetal circulation*Alveolar capillary dysplasia with pulmonary venous misalignment ...
Panniculitis, Peritoneal [C06.844.600] Panniculitis, Peritoneal * Peritoneal Fibrosis [C06.844.610] Peritoneal Fibrosis ...
A condition with trapped gas or air in the PERITONEAL CAVITY, usually secondary to perforation of the internal organs such as ...
Panniculitis, Peritoneal [C06.844.600] * Peritoneal Fibrosis [C06.844.610] * Peritoneal Neoplasms [C06.844.620] ... Peritoneal Sclerosis Previous Indexing. Peritoneal Dialysis (1981-2009). Peritoneal Diseases (1964-2009). See Also. Peritoneal ... Peritoneal Sclerosis Narrower Concept UI. M0528148. Terms. Peritoneal Sclerosis Preferred Term Term UI T732626. Date12/30/2008 ... Encapsulating Peritoneal Sclerosis Narrower Concept UI. M0528149. Terms. Encapsulating Peritoneal Sclerosis Preferred Term Term ...
... peritoneal based masses are present with no ascites.7 Imaging presentation of this tumour is similar to peritoneal ... Mesenteric panniculitis presents as a well-defined fatty mass in the root of mesentery. Diffuse homogenous hyperechogenicity ... FIGURE 6: Mesenteric panniculitis. Transverse grey scale ultrasound image (a) of the abdomen in a 63-year-old male reveals ... FIGURE 4: Malignant peritoneal mesothelioma. Contrast enhanced CT images - axial (a), coronal (b) and sagittal (c) reformatted ...
... erythema nodosum Erythema Nodosum Erythema nodosum is a specific form of panniculitis characterized by tender, red or violet, ... Free perforation into the peritoneal cavity is unusual.. Chronic disease causes a variety of systemic symptoms, including fever ...
Solitary fibrous peritoneal tumors have also been described, which may be benign or malignant. These much more commonly arise ... Coulier B. Mesenteric panniculitis. Part 2: prevalence and natural course: MDCT prospective study. JBR-BTR. 2011 Sep-Oct. 94 (5 ... Courtesy of BioMed Central Ltd, Springer Nature [Arda K, Kizilkanat KT, Aydin H. CT and MRI aspect of mesenteric panniculitis. ... Courtesy of BioMed Central Ltd, Springer Nature [Arda K, Kizilkanat KT, Aydin H. CT and MRI aspect of mesenteric panniculitis. ...
Peritoneal biopsy is also helpful in nonascitic cases. Findings are positive in 42% of patients with abdominal TB. ... Ege G, Akman H, Cakiroglu G. Mesenteric panniculitis associated with abdominal tuberculous lymphadenitis: a case report and ... Where laparoscopy is not available, percutaneous peritoneal biopsy and diagnostic ascitic tap (if ascites are present) for ...
After being diagnosed with SPTCL (Subcutaneous Panniculitis-like 20. 2. “Change of Taste� ... Betsy Brockett Leechburg, PA Survivor of Peritoneal Mesothelioma. Twist on Cancer:I was diagnosed with cancer at the age of 28 ... Katherine Beer Naperville, Illinois Survivor of Subcutaneous Panniculitis-like T-cell Lymphoma (SPTCL) ...
O Peritoneal abscess,O Peritoneal effusion,O Peritoneal mesothelioma,O Peritonitis,O Periungual teleangiectasia,O Perivascular ... O Panniculitis,O Pansynostosis,O Panuveitis,O Papillary cystadenoma of the epididymis,O Papillary renal cell carcinoma,O ... O Primary peritoneal carcinoma,O Primary testicular failure,O Primitive neuroectodermal tumor,O Primitive reflex,O Primum ...
Rodriguez E, Martinez JA, Torres M, Nubiiola A, Buges J. Lobular panniculitis associated with ciprofloxacin. Br Med J. 1990;300 ... Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. J Antimicrob ... lobular panniculitis, photoinduced acute exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms (DRESS ...
... the severity of the peritoneal episodes may mimic acute appendicitis and many patients have undergone appendicectomy [11]. ... panniculitis and vasculitis [33]. ...
Cold Panniculitis (Popsicle Panniculitis). Herpetic Gingivostomatitis. Meningococcemia. Urticaria. Staphylococcal Scalded Skin ... Diagnostic Peritoneal Lavage. Seat Belt Injury. Grey Turner Sign and Cullen Sign. Impaled Foreign Body. Abdominal Evisceration ...
... panniculitis, and calcinosis cutis. Scalp involvement is common, with an erythematous to violaceous, psoriasiform dermatitis. ... Most patients with NSF are undergoing hemodialysis or peritoneal dialysis or have had a renal transplantation. ...
The surgical approach (open, laparoscopic, or robotic) and plane of placement (retro-rectus, intra-peritoneal, or pre- ... Panniculitis [abdomen]. R60.9. Edema, unspecified [lipedema]. ICD-10 codes not covered for indications listed in the CPB:. ... peritoneal) were at the discretion of the surgeon. Patients were characterized as high-risk for a surgical site occurrence (SSO ...
4. Klibanov OM, Vickery S, Nortey C: Successful treatment of infective panniculitis with daptomycin in a pregnant, morbidly ... and by peritoneal dialysis (approximately 11% of the administered dose is removed over 48 hours). The use of high-flux dialysis ... and continuous ambulatory peritoneal dialysis (CAPD) (84%). The protein binding of daptomycin in adult subjects with moderate ... continuous ambulatory peritoneal dialysis; AUC0-∞, area under the concentration-time curve extrapolated to infinity; AUCss, ...
Recurrent Primary Peritoneal Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, ...
Naylor E, Hu S, Robinson-Bostom L. Nephrogenic systemic fibrosis with septal panniculitis mimicking erythema nodosum. J Am Acad ... some have never undergone dialysis and others have received only peritoneal dialysis. ...
peritoneal absorption. Uptake of substances from the peritoneal cavity. peritoneal cavity. The space enclosed by the peritoneum ... panniculitis. General term for inflammation of adipose tissue, usually of the skin, characterized by reddened subcutaneous ... peritoneal dialysis. Dialysis fluid being introduced into and removed from the peritoneal cavity. ... Inflammation of the peritoneal capsule of the liver. perimenopause. The period of time before menopause when a womans body ...
M54.0 Panniculitis affecting regions of neck and back M54.1 Radiculopathy M54.2 Cervicalgia M54.3 Sciatica M54.4 Lumbago with ... K66.0 Peritoneal adhesions K66.1 Hemoperitoneum K66.8 Other specified disorders of peritoneum K66.9 "Disorder of peritoneum, ... "Panniculitis, unspecified" M79.4 Hypertrophy of (infrapatellar) fat pad M79.5 Residual foreign body in soft tissue M79.6 Pain ... N73.6 Female pelvic peritoneal adhesions N73.8 Other specified female pelvic inflammatory diseases N73.9 "Female pelvic ...
Naylor E, Hu S, Robinson-Bostom L. Nephrogenic systemic fibrosis with septal panniculitis mimicking erythema nodosum. J Am Acad ... some have never undergone dialysis and others have received only peritoneal dialysis. ...
C. K. Cebra, Tornquist, S. J., and Reed, S. K., "Collection and analysis of peritoneal fluid from healthy llamas and alpacas." ... L. H. Waitt, Cebra, C. K., Tornquist, S. J., and Löhr, C. V., "Panniculitis in a horse with peripancreatitis and pancreatic ... M. N. Saulez, Cebra, C. K., and Dailey, M., "Comparative biochemical analyses of venous blood and peritoneal fluid from horses ...
  • Mesenteric panniculitis as a possible cause of fever of unknown origin. (bvsalud.org)
  • Mesenteric panniculitis is a non-neoplastic condition involving inflammation and fibrosis of the small bowel mesentery . (bvsalud.org)
  • The diagnosis of mesenteric panniculitis had been established 2 weeks prior based on an abdominal computerized tomography scan. (bvsalud.org)
  • Extensive diagnostic investigations during his hospitalisation were unrevealing, and the symptoms were ultimately attributed to the mesenteric panniculitis . (bvsalud.org)
  • This case suggests that mesenteric panniculitis merits consideration in the differential diagnosis of fever of unknown origin . (bvsalud.org)
  • A Mesenteric panniculitis is an uncommon disorder with unknown etiology. (elsevierpure.com)
  • We report computed tomography findings of mesenteric panniculitis in an adult patient with renal colic. (elsevierpure.com)
  • Canan, A 2016, ' Mimicker of Renal Colic: Mesenteric Panniculitis ', Journal of Nepal Health Research Council , vol. 14, no. 33, pp. 132-134. (elsevierpure.com)
  • Peritoneal fibrosis is a common complication in patients receiving PERITONEAL DIALYSIS and contributes to its gradual decrease in efficiency. (nih.gov)
  • Most patients with NSF are undergoing hemodialysis or peritoneal dialysis or have had a renal transplantation. (medscape.com)
  • Although most patients with nephrogenic systemic fibrosis have undergone hemodialysis for renal failure, some have never undergone dialysis and others have received only peritoneal dialysis. (medscape.com)
  • Capsule?CAPD: Continuous ambulatory peritoneal dialysis?Caps: Capsules?CAPS: Cryopyrin-Associated Periodic Syndromes disorders?CAPTIA Syph G: ?CAPTIA Syph M: ?CAST: Cardiac arrhythmia suppression trials?CAT: Computerized axial tomography?Cataplasm. (kuwaitpharmacy.com)
  • A condition with trapped gas or air in the PERITONEAL CAVITY, usually secondary to perforation of the internal organs such as the LUNG and the GASTROINTESTINAL TRACT, or to recent surgery. (uchicago.edu)
  • The small-bowel mesentery and portions of the large-bowel mesentery are mobile within the peritoneal cavity. (medscape.com)
  • a dominant omental mass was removed and 2-3 mm peritoneal nodules on the distal small bowel mesentery and a bulky mass around the root of the superior mesenteric vessels were noted. (fortuneonline.org)
  • Although primary neoplasms arising in the mesentery are rare, the mesentery is a major avenue for the dissemination of tumours, which can spread through hematogenous, lymphatic, direct or peritoneal seeding. (sajr.org.za)
  • Il s'agit d'une étude transversale, monocentrique et descriptive, durant 12 mois, incluant les patients âgés d'au moins 18 ans admis en réanimation polyvalente pour un sepsis ou choc septique. (bvsalud.org)
  • Cette étude documentaire, analyse les données des patients diagnostiqués et traités pour tuberculose de 2007 à 2017 en RDC. (bvsalud.org)
  • 1. F-18 FDG uptake in subcutaneous panniculitis-like T-cell lymphoma. (nih.gov)
  • 2. F-18 FDG PET images for subcutaneous panniculitis-like T-cell lymphoma. (nih.gov)
  • 3. Positron-emission tomography findings indicating the involvement of the whole body skin in subcutaneous panniculitis-like T cell lymphoma. (nih.gov)
  • 5. 18F-FDG PET/CT-Guided Diagnosis and Evaluation of Treatment Response to Cyclosporine A in Maldistributed Subcutaneous Panniculitis-like T-Cell Lymphoma Without Typical Skin Rash. (nih.gov)
  • 6. Subcutaneous panniculitis-like T-cell lymphoma in a 26-month-old child with a review of the literature. (nih.gov)
  • 7. A rare case of fever of unknown origin: subcutaneous panniculitis-like T-cell lymphoma (SPTCL). (nih.gov)
  • 8. Positron emission tomography revealed diffuse involvement of the lower legs and occult extracutaneous lesions in subcutaneous panniculitis-like T-cell lymphoma. (nih.gov)
  • 9. Relapsed subcutaneous panniculitis-like T cell lymphoma evaluated by FDG PET/CT: A clinical case report. (nih.gov)
  • 10. Subcutaneous panniculitis-like T-cell lymphoma with extracutaneous dissemination demonstrated on FDG PET/CT. (nih.gov)
  • 11. Subcutaneous panniculitis-like T-cell lymphoma with bone marrow involvement. (nih.gov)
  • 12. Inverted FDG Uptake Pattern in Subcutaneous Panniculitis-Like T-Cell Lymphoma. (nih.gov)
  • 13. Role of PET imaging in peritoneal involvement of subcutaneous panniculitis-like T-cell lymphoma. (nih.gov)
  • 14. Positron emission tomography-computed tomography in subcutaneous panniculitis-like T-cell lymphoma. (nih.gov)
  • 15. Familial aggregation of subcutaneous panniculitis-like T cell lymphoma: A case report of monozygotic twin brothers. (nih.gov)
  • 16. [Concurrent subcutaneous panniculitis-like T-cell lymphoma and myelodysplastic syndrome with fibrosis]. (nih.gov)
  • 18. Macrophage activation syndrome leading to fatality in subcutaneous panniculitis-like T cell lymphoma. (nih.gov)
  • 19. Full facial edema: a novel presentation of subcutaneous panniculitis-like T-cell lymphoma. (nih.gov)
  • I have Subcutaneous Panniculitis-Like T-cell lymphoma stage 4a. (cancer.org)
  • Mucinous carcinomatosis is the most likely diagnosis of cystic peritoneal masses. (radiologyassistant.nl)
  • Pseudomyxoma peritonei is less common, but looks quite similar to peritoneal carcinomatosis. (radiologyassistant.nl)
  • CT imaging review of uncommon peritoneal-based neoplasms: beyond carcinomatosis. (nih.gov)
  • Non-neoplastic conditions mimicking peritoneal carcinomatosis at CT imaging. (nih.gov)
  • [ 3 ] The term sclerosing mesenteritis now represents an appropriate umbrella for numerous terms, such as mesenteric lipodystrophy, mesenteric sclerosis, retractile mesenteritis, and mesenteric panniculitis. (medscape.com)
  • Benign multicystic mesothelioma and peritoneal inclusion cysts: are they the same clinical and histopathological entities? (nih.gov)
  • In Peritoneum and Mesentery - part I: Anatomy the normal anatomy and physiology of the peritoneum and peritoneal cavity are discussed. (radiologyassistant.nl)
  • Chylous ascites is the accumulation of a milklike peritoneal fluid rich in triglycerides , due to the presence of thoracic or intestinal lymph in the abdominal cavity. (medscape.com)
  • Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. (wakehealth.edu)
  • Warady BA, Bohl V, Alon U, Hellerstein S. Symptomatic peritoneal calcification in a child: treatment with tidal peritoneal dialysis. (childrensmercy.org)
  • Although most patients with nephrogenic systemic fibrosis have undergone hemodialysis for renal failure, some have never undergone dialysis and others have received only peritoneal dialysis. (medscape.com)
  • Peritoneal Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (childrensmercy.org)
  • Representative examples include peritonitis and panniculitis. (nih.gov)
  • Mesenteric panniculitis is a rare disease caused by idiopathic inflammation of adipose tissue, most commonly affecting the mesentery of the small bowel. (nih.gov)
  • Inflammation of the ADIPOSE TISSUE in the MESENTERY, a form of peritoneal panniculitis, It is characterized by the presence of MULTINUCLEATED GIANT CELLS and lipid-laden MACROPHAGES in the mesentery. (bvsalud.org)
  • This graph shows the total number of publications written about "Peritoneal Diseases" by people in this website by year, and whether "Peritoneal Diseases" was a major or minor topic of these publications. (childrensmercy.org)
  • Below are the most recent publications written about "Peritoneal Diseases" by people in Profiles. (childrensmercy.org)
  • We will discuss the differential diagnosis of cystic and solid peritoneal and mesenteric masses. (radiologyassistant.nl)
  • Possible cause is Mesenteric Panniculitis but I think it is liver. (cancer.org)
  • 17. Remarkable FDG Uptake in Numerous Granulomatous Panniculitis Lesions: A Case Report. (nih.gov)